General features | Control | CWAT | CWAT +  | Intervention effects | |||||
---|---|---|---|---|---|---|---|---|---|
Baseline (n = 20) | 12 weeks (n = 19) | Baseline (n = 20) | 12 weeks (n = 20) | Baseline (n = 19) | 12 weeks (n = 17) | CWAT vs control | CWAT + vs. control | CWAT + vs. CWAT | |
Age (years) | 53.8 ± 8.5 | 54.2 ± 8.8 | 52.4 ± 8.7 | 52.8 ± 8.7 | 53.8 ± 9.2 | 54.7 ± 9.5 |  |  |  |
Sex (m/f) | 6/14 | 6/13 | 7/13 | 7/13 | 8/11 | 7/10 | Â | Â | Â |
Body weight (kg) | 75.8 ± 11.5 | 77.2 ± 11.6 | 76.6 ± 14.6 | 76.9 ± 14.7 | 74.7 ± 12.7 | 72.6 ± 12.5 | − 0.28 (− 2.01, 1.46) | − 2.19 (− 4.00, − 0.37)* | − 1.91 (− 3.70, − 0.12)* |
Body height (cm) | 169.7 ± 7.9 | 170.4 ± 7.3 | 171.1 ± 7.9 | 171.1 ± 8.0 | 171.3 ± 10.3 | 170.2 ± 10.2 |  |  |  |
BMI (kg/m2) | 26.3 ± 3.8 | 26.6 ± 4.1 | 26.2 ± 4.9 | 26.3 ± 4.9 | 25.4 ± 3.6 | 25.0 ± 3.6 | − 0.06 (− 0.65, 0.52) | − 0.72 (− 1.33, − 0.14)* | − 0.66 (− 1.26, − 0.06)* |
Waist circumference (cm) | 88.5 ± 10.0 | 90.9 ± 10.7 | 89.2 ± 13.9 | 88.0 ± 14.3 | 87.2 ± 10.1 | 85.1 ± 9.2 | − 2.87 (− 5.72, − 0.01)* | − 4.11 (− 7.09, − 1.13)* | − 1.24 (− 4.20, 1.70) |
Hip circumference (cm) | 98.2 ± 9.3 | 100.2 ± 10.4 | 99.7 ± 11.2 | 98.6 ± 11.4 | 97.4 ± 8.0 | 95.6 ± 7.2 | − 2.46 (− 5.60, 0.67) | − 3.48 (− 6.75, − 0.21)* | − 1.02 (− 4.25, 2.22) |
Waist-to-hip-ratio | 0.90 ± 0.08 | 0.91 ± 0.08 | 0.89 ± 0.08 | 0.89 ± 0.10 | 0.90 ± 0.07 | 0.89 ± 0.07 | -0.01 (− 0.04, 0.02) | − 0.01 (− 0.04, 0.02) | − 0.01 (− 0.04, 0.03) |
Lean mass (kg) | 46.5 ± 7.1 | 47.3 ± 6.5 | 48.3 ± 6.5 | 48.6 ± 8.6 | 47.9 ± 9.1 | 47.3 ± 9.2 | 0.21 (− 0.73, 1.11) | − 0.36 (− 1.35, 0.63) | − 0.57 (− 1.55, 0.41) |
Fat mass (kg) | 26.0 ± 9.4 | 26.5 ± 10.0 | 24.5 ± 9.9 | 24.6 ± 10.1 | 23.1 ± 6.2 | 21.9 ± 7.3 | − 0.26 (− 1.70, 1.18) | − 1.67 (− 3.21, − 0.14)* | − 1.41 (− 3.21, − 0.14) |
Fat mass (%) | 34.0 ± 9.6 | 33.9 ± 9.9 | 31.9 ± 9.5 | 31.8 ± 9.4 | 31.5 ± 6.6 | 30.4 ± 8.0 | − 0.3 (− 1.6, 1.1) | − 1.5 (− 2.9, − 0.1)* | − 1.3 (− 2.6, 0.2) |
Energy intake (kcal) | 1503 ± 255 | 1600 ± 450 | 1726 ± 348 | 1793 ± 264 | 1635 ± 351 | 1595 ± 630 | − 87 (− 330, 505) | − 120 (− 557, 317) | − 33 (− 437, 371 |
Fat (g) | 53 ± 16 | 56 ± 23 | 64 ± 19 | 65 ± 11 | 58 ± 14 | 60 ± 26 | − 6 (− 23, 19) | − 4 (− 27, 19) | 2 (− 19, 23) |
Protein (g) | 71 ± 15 | 76 ± 20 | 68 ± 18 | 74 ± 22 | 73 ± 18 | 68 ± 24 | 4 (− 22, 31) | − 10 (− 37, 17) | − 14 (− 40, 11) |
Carbohydrate (g) | 170 ± 30 | 179 ± 42 | 196 ± 42 | 208 ± 40 | 189 ± 44 | 180 ± 75 | − 8 (− 49, 34) | − 10 (− 54, 33) | − 3 (− 43, 38) |
HbA1c (%) | 5.3 ± 0.3 |  | 5.4 ± 0.3 |  | 5.3 ± 0.4 |  |  |  |  |
Smoking status (n) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Never | 0 | Â | 0 | Â | 1 | Â | Â | Â | Â |
Former | 5 | Â | 7 | Â | 3 | Â | Â | Â | Â |
Never | 15 | Â | 13 | Â | 15 | Â | Â | Â | Â |
Chronic disease (n) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Respiratory | 1 |  | 0 |  | 2 |  |  |  |  |
 Cardiovascular | 0 |  | 5 |  | 1 |  |  |  |  |
 Medication (n) |  |  |  |  |  |  |  |  |  |
 Beta blocker | 0 |  | 3 |  | 2 |  |  |  |  |
 Angiotensin II-antagonist | 0 |  | 2 |  | 1 |  |  |  |  |
 Bronchodilator | 1 |  | 0 |  | 1 |  |  |  |  |